Shopping Cart 0
Cart Subtotal
USD 0

Centene Corp (CNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health solutions through its specialty services companies. It provides a comprehensive range of managed healthcare products and services including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care (LTC), Foster Care, dual-eligible individuals (Duals), the Aged, blind or disabled program (ABD), Medicare and Health Insurance Marketplace. Centene through its specialty services companies offers life and health management, behavioral health and specialty rehabilitation therapies, managed vision, long-term care programs, telehealth services and pharmacy benefits management to healthcare organizations, employer groups, state programs and other commercial organizations. The company along with its subsidiaries operates across the US. Centene is headquartered in Saint Louis, Missouri, the US.

Centene Corp (CNC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centene Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centene Corp, Medical Devices Deals, 2012 to YTD 2018 9

Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Centene Corp, Pharmaceuticals & Healthcare, Deal Details 11

Equity Offering 11

Centene Files Registration Statement For Public Offering Of Common Stock For USD 15.3 Million 11

Debt Offering 12

Centene Raises Additional USD200 Million in Public Offering 4.75% Senior Notes Due 2022 12

Centene Completes Public Offering Of Notes Due 2022 For USD 300 Million 13

Centene Completes Public Offering Of Notes Due 2017 For USD 175 Million 14

Asset Transactions 15

CVS Caremark Completes Acquisition Of Medicare PDP Business From Health Net For USD 160 Million 15

Acquisition 16

Centene Acquires Agate Resources For USD114 Million 16

Centene Completes Acquisition of Stake in Ribera Salud 17

Centene Completes Acquisition Of Majority Stake In U.S. Medical Management For USD213 Million 18

Centene Completes Acquisition Of AcariaHealth, Specialty Pharmacy Company, For USD 152 Million 19

Centene Corp-Key Competitors 20

Centene Corp-Key Employees 21

Centene Corp-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Joint Venture 24

Recent Developments 25

Strategy And Business Planning 25

Oct 10, 2018: Centene announces 2019 exchange participation 25

Financial Announcements 26

Oct 23, 2018: Centene reports 2018 third quarter results and increases 2018 guidance 26

Feb 06, 2018: Centene Reports 2017 Results And Increases 2018 Guidance 28

Dec 14, 2017: Centene Announces 2018 Guidance And Confirms 2017 Guidance 31

Oct 24, 2017: Centene Reports 2017 Third Quarter Results & Updates 2017 Guidance 32

Jul 25, 2017: Centene Reports 2017 Second Quarter Results & Raises 2017 Guidance 34

Apr 25, 2017: Centene Reports 2017 First Quarter Results & Updates 2017 Guidance 36

Feb 07, 2017: Centene Reports 2016 Fourth Quarter And Full Year Results 38

Corporate Communications 40

Jun 08, 2018: Centene Announces Leadership Rotation To Support Company's Growth And Development 40

Feb 05, 2018: Centene Appoints Jessica L. Blume As Board Director 41

Nov 16, 2017: Centene Announces Organizational Enhancements and Several Key Leadership Appointments 42

Legal and Regulatory 43

Jan 03, 2018: Nebraska Total Care earns NCQA Accreditation 43

Dec 06, 2017: Health Net Federal Services Earns URAC Health Utilization Management And Case Management Accreditations 44

Sep 19, 2017: Coordinated Care Awarded Commendable Accreditation Status From NCQA 45

Other Significant Developments 46

Jul 19, 2017: Centene Partners With Schnucks And People's Health Centers To Open Ferguson Clinic 46

Appendix 47

Methodology 47

About GlobalData 47

Contact Us 47

Disclaimer 47


List Of Figure

List of Figures

Centene Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centene Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centene Corp, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Centene Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centene Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centene Corp, Medical Devices Deals, 2012 to YTD 2018 9

Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Centene Files Registration Statement For Public Offering Of Common Stock For USD 15.3 Million 11

Centene Raises Additional USD200 Million in Public Offering 4.75% Senior Notes Due 2022 12

Centene Completes Public Offering Of Notes Due 2022 For USD 300 Million 13

Centene Completes Public Offering Of Notes Due 2017 For USD 175 Million 14

CVS Caremark Completes Acquisition Of Medicare PDP Business From Health Net For USD 160 Million 15

Centene Acquires Agate Resources For USD114 Million 16

Centene Completes Acquisition of Stake in Ribera Salud 17

Centene Completes Acquisition Of Majority Stake In U.S. Medical Management For USD213 Million 18

Centene Completes Acquisition Of AcariaHealth, Specialty Pharmacy Company, For USD 152 Million 19

Centene Corp, Key Competitors 20

Centene Corp, Key Employees 21

Centene Corp, Subsidiaries 22

Centene Corp, Joint Venture 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Centene Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health solutions through its specialty services companies. It provides a comprehensive range of managed healthcare products and services including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care (LTC), Foster Care, dual-eligible individuals (Duals), the Aged, blind or disabled program (ABD), Medicare and Health Insurance Marketplace. Centene through its specialty services companies offers life and health management, behavioral health and specialty rehabilitation therapies, managed vision, long-term care programs, telehealth services and pharmacy benefits management to healthcare organizations, employer groups, state programs and other commercial organizations. The company along with its subsidiaries operates across the US. Centene is headquartered in Saint Louis, Missouri, the US.

Centene Corp (CNC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centene Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centene Corp, Medical Devices Deals, 2012 to YTD 2018 9

Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Centene Corp, Pharmaceuticals & Healthcare, Deal Details 11

Equity Offering 11

Centene Files Registration Statement For Public Offering Of Common Stock For USD 15.3 Million 11

Debt Offering 12

Centene Raises Additional USD200 Million in Public Offering 4.75% Senior Notes Due 2022 12

Centene Completes Public Offering Of Notes Due 2022 For USD 300 Million 13

Centene Completes Public Offering Of Notes Due 2017 For USD 175 Million 14

Asset Transactions 15

CVS Caremark Completes Acquisition Of Medicare PDP Business From Health Net For USD 160 Million 15

Acquisition 16

Centene Acquires Agate Resources For USD114 Million 16

Centene Completes Acquisition of Stake in Ribera Salud 17

Centene Completes Acquisition Of Majority Stake In U.S. Medical Management For USD213 Million 18

Centene Completes Acquisition Of AcariaHealth, Specialty Pharmacy Company, For USD 152 Million 19

Centene Corp-Key Competitors 20

Centene Corp-Key Employees 21

Centene Corp-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Joint Venture 24

Recent Developments 25

Strategy And Business Planning 25

Oct 10, 2018: Centene announces 2019 exchange participation 25

Financial Announcements 26

Oct 23, 2018: Centene reports 2018 third quarter results and increases 2018 guidance 26

Feb 06, 2018: Centene Reports 2017 Results And Increases 2018 Guidance 28

Dec 14, 2017: Centene Announces 2018 Guidance And Confirms 2017 Guidance 31

Oct 24, 2017: Centene Reports 2017 Third Quarter Results & Updates 2017 Guidance 32

Jul 25, 2017: Centene Reports 2017 Second Quarter Results & Raises 2017 Guidance 34

Apr 25, 2017: Centene Reports 2017 First Quarter Results & Updates 2017 Guidance 36

Feb 07, 2017: Centene Reports 2016 Fourth Quarter And Full Year Results 38

Corporate Communications 40

Jun 08, 2018: Centene Announces Leadership Rotation To Support Company's Growth And Development 40

Feb 05, 2018: Centene Appoints Jessica L. Blume As Board Director 41

Nov 16, 2017: Centene Announces Organizational Enhancements and Several Key Leadership Appointments 42

Legal and Regulatory 43

Jan 03, 2018: Nebraska Total Care earns NCQA Accreditation 43

Dec 06, 2017: Health Net Federal Services Earns URAC Health Utilization Management And Case Management Accreditations 44

Sep 19, 2017: Coordinated Care Awarded Commendable Accreditation Status From NCQA 45

Other Significant Developments 46

Jul 19, 2017: Centene Partners With Schnucks And People's Health Centers To Open Ferguson Clinic 46

Appendix 47

Methodology 47

About GlobalData 47

Contact Us 47

Disclaimer 47


List Of Figure

List of Figures

Centene Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centene Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centene Corp, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Centene Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Centene Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Centene Corp, Medical Devices Deals, 2012 to YTD 2018 9

Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Centene Files Registration Statement For Public Offering Of Common Stock For USD 15.3 Million 11

Centene Raises Additional USD200 Million in Public Offering 4.75% Senior Notes Due 2022 12

Centene Completes Public Offering Of Notes Due 2022 For USD 300 Million 13

Centene Completes Public Offering Of Notes Due 2017 For USD 175 Million 14

CVS Caremark Completes Acquisition Of Medicare PDP Business From Health Net For USD 160 Million 15

Centene Acquires Agate Resources For USD114 Million 16

Centene Completes Acquisition of Stake in Ribera Salud 17

Centene Completes Acquisition Of Majority Stake In U.S. Medical Management For USD213 Million 18

Centene Completes Acquisition Of AcariaHealth, Specialty Pharmacy Company, For USD 152 Million 19

Centene Corp, Key Competitors 20

Centene Corp, Key Employees 21

Centene Corp, Subsidiaries 22

Centene Corp, Joint Venture 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Centene Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.